Early results of infragenicular revascularization based solely on duplex arteriography  by Proia, Richard R. et al.
DA for assessment and interventional planning of arterial
disease above the knee, but have suggested limitations of
DA for below-knee evaluation.3,4 Other authors recom-
mend that DA be used only as a screening tool to help
select patients who should then have CA before perfor-
mance of any infrainguinal intervention.5-7
Using DA alone to image the infragenicular arteries
and plan bypass procedures has received increasing atten-
tion recently but is more controversial. Multiple studies
have reported equivalent results when comparing DA with
CA for imaging of the infrapopliteal arterial tree.8-12 Only
a limited number of studies have examined DA as the sole
preoperative study for planning infragenicular bypass
grafting. Ligush et al13 found DA as effective as CA for
predicting distal revascularization procedures in a group of
36 patients. Ascher et al14 successfully performed infra-
popliteal bypass graft based on DA alone in 89% of
patients presenting with critical limb ischemia. Mazzariol
et al15 recently reported a series of 57 patients who had
infrapopliteal bypass graft based on DA alone with 1- and
3-month patency rates of 90% and 83%, respectively.15
To further delineate the role of DA for planning infra-
genicular bypass graft, we examined our initial experience
with DA as the sole preoperative imaging study. To deter-
mine if DA-guided bypass gives acceptable results, we
compared patency and limb salvage rates of the DA group
with a demographically matched historical control group
who underwent similar procedures based on CA alone.
Routine use of duplex arteriography (DA) as the sole
preoperative imaging study for planning lower extremity
revascularization has generated significant debate in the
literature. As vascular technologists become adept at per-
forming DA and surgeons become confident with the
results generated, DA-guided lower extremity bypass pro-
cedures are becoming more commonly performed.
Many authors have reported excellent results in guid-
ing treatment of patients with supragenicular peripheral
arterial occlusive disease with DA alone. In 1989,
Cossman et al1 showed good outcomes with duplex to
screen patients for disease from the iliac arteries to the
popliteal arteries. Polak et al2 confirmed these findings by
showing equivalent results between DA and contrast arte-
riography (CA) for determining the extent of femoral-
popliteal disease. Other studies have shown the benefit of
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Purpose: Recent reports have both advocated and questioned the utility of duplex arteriography (DA) as the sole pre-
operative imaging modality for planning infragenicular revascularization. This study compares the outcome of patients
with critical limb ischemia who underwent infragenicular vein grafts on the basis of DA alone versus conventional pre-
operative contrast arteriography (CA).
Methods: The study group is composed of 23 consecutive patients who underwent infragenicular vein bypass grafting
solely on the basis of preoperative DA from 1998 to 1999. They were compared with 50 consecutive patients who
underwent infragenicular vein bypass grafting after CA from 1996 to 1998. Peak systolic velocity and end-diastolic
velocity of potential target arteries were recorded during DA studies. In situ saphenous vein grafts were used prefer-
entially, and technical adequacy of all grafts was assessed with completion duplex or arteriography.
Results: DA and CA groups were comparable on the basis of age and risk factors. In one limb (4%), the target artery
selected by DA was abandoned because of dense calcification. No other revision in target or inflow artery was required
on the basis of intraoperative completion studies. At 1 year, primary graft patency (78% vs 70%, P = .72) and limb sal-
vage (70% vs 81%, P = .21) were comparable between the two groups. In the DA group, mean preoperative target artery
peak systolic velocity in patent versus failed grafts was 49 ± 18 cm/s versus 31 ± 9 cm/s (P = .04), whereas mean end-
diastolic velocity was 22 ± 7 cm/s versus 14 ± 8 cm/s (P = .08).
Conclusion: Infragenicular revascularization directed by DA alone provides early graft patency and limb salvage rates
comparable to similar procedures that are based on CA. Preoperative DA target artery velocities may predict outcome
and improve target selection. These initial results justify further clinical testing of DA as the primary imaging modal-
ity for planning infragenicular vein grafts. (J Vasc Surg 2001;33:1165-70.)
Our study also examines the potential usefulness of target
artery peak systolic velocity (PSV) and end-diastolic veloc-
ity (EDV) measurements taken during preoperative DA
studies.
METHODS
We performed a retrospective review of 23 consecutive
patients who underwent infragenicular vein bypass graft
based on DA alone between February 1998 and
December 1999. Before this series began, close correla-
tion between DA and CA was seen in 18 patients who
were studied with both imaging modalities. All patients
referred to one of the senior authors (D.B.W.) without
prior arteriographic studies were enrolled in the DA study
group. The indication for operation in all patients was crit-
ical limb ischemia to create homogeneous populations for
comparison. Because the routine use of DA for planning
supragenicular procedures is less controversial, we chose
to exclude these patients. The number of patients who
underwent infragenicular bypass graft for popliteal
aneurysm or with synthetic conduit during the study
period was so small that their inclusion would confound
the data analysis.
The selection of the most appropriate comparison
group was problematic. Because one senior author
(D.B.W.) pursued the safety and efficacy of DA, the use of
contemporaneous patients referred to other senior authors
as the comparison group added an unacceptable selection
bias. A more appropriate comparison group seemed to be
patients whose procedures were planned and performed
similarly by any among the senior authors just before the
introduction of DA. Thus, the comparison group included
50 consecutive patients who underwent infragenicular
vein grafts for critical ischemia based on CA alone between
January 1996 and January 1998. All surgical procedures
were performed with similar standard techniques that did
not change from 1996 to 1999. The study group and con-
trol groups were compared to determine if any differences
in sex, age, diabetes, smoking, coronary artery disease,
hypertension, or renal failure were present. All DA studies
and surgical procedures were done at the Dartmouth-
Hitchcock Medical Center.
Preoperative DA was performed with the ATL 3000
or ATL 5000 duplex ultrasound machine (Philips ATL,
Bothell, Wash). Patients undergoing DA had complete
mapping of the arterial anatomy of the ischemic limb,
which required approximately 1 hour to complete. This
entailed duplex interrogation of the full length of all lower
extremity arteries. Significant stenoses were identified by a
twofold or greater increase in PSV, whereas an occlusion
was defined as a well-seen artery with absent blood flow.
PSV and EDV were determined with spectral waveforms
obtained from each arterial segment as viewed during B-
mode imaging. The operating surgeon chose proximal and
distal anastomotic sites based on recorded DA findings.
Any questions about reported DA data were addressed
through direct communication by the surgeon with the
technologist who performed the study. Along with criteria
such as vessel diameter, the amount of calcification pres-
ent, and condition of the vessel distally, velocity data were
used by the primary surgeon to help choose the best tar-
get. At the outset of our study, there were no specific
velocity criteria for selecting distal target arteries. In gen-
eral, higher DA target artery velocities in nondiseased
arterial segments were thought to represent more optimal
targets. For the purposes of this study, when target vessels
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Fig 1. Kaplan-Meier life table comparing primary graft patency
of duplex arteriography (DA) group versus conventional arteri-
ography (CA) group. Numbers at bottom of graph represent
number of patients at risk to fail in each group at beginning of
each time interval. Statistical analysis performed with Mantel-Cox
log-rank test.
Fig 2. Kaplan-Meier life table comparing limb salvage rates of
duplex arteriography (DA) group with conventional arteriogra-
phy (CA) group. Numbers at bottom of graph represent number
of limbs at risk in each group at beginning of each time period.
SE > 10% when graph line is dashed. Statistical analysis performed
with Mantel-Cox log-rank test.
were not adequately identified by DA, CA or surgical
exploration of target arteries was performed before ampu-
tation. These patients were excluded. During the study
period there were no patients in whom CA identified a tar-
get not seen with DA.
All patients had duplex vein mapping to determine the
length and quality of conduit available for bypass grafting.
In situ saphenous vein (ISSV) was used preferentially for
conduit, with reversed saphenous vein, composite vein, or
arm vein used when ISSV was unavailable. All grafts were
assessed intraoperatively for technical adequacy with com-
pletion duplex or arteriography.
Graft surveillance with duplex ultrasound scan and
limb pressure measurements was performed at 1, 4, 6, and
12 months for all patients in the first postoperative year.
Subsequently, patients had surveillance every 6 months to
assess graft patency. Limb salvage and patency rates were
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determined from the date of surgery to the date of ampu-
tation or thrombosis. A failed graft was any graft that
either occluded or did not provide the additional blood
flow necessary to avoid a major amputation.
Patency and limb salvage rates for the study and control
groups were compared with Kaplan-Meier life-table analysis
and Mantel-Cox log-rank analysis. Demographic character-
istics of the two groups were compared with the Fisher exact
test. DA-derived target artery velocity measurements from
patent and failed grafts were compared with both the Mann-
Whitney U test and the unpaired Student t test. Statistical
significance was assumed for P values less than .05.
RESULTS
From 1998 to 1999, DA alone was used to direct
infragenicular revascularization in 23 consecutive patients.
The comparison group consisted of 50 consecutive
Table I. Patient demographics
DA CA P value*
No. 23 50 N/A
Age and sex
Mean age (y ± SEM) 71 ± 2 68 ± 2 .42
Male (%) 65 72 .59
Comorbidities
CAD (%) 39 42 .87
DM (%) 73 66 .59
Smoking (%) 39 40 > .99
Hypertension (%) 26 56 .04
Renal failure (%) 17 16 > .99
Indication
Limb salvage (%) 100 100 N/A
*All P values determined with Fisher exact test.
CA, Contrast arteriography; CAD, coronary artery disease; DA, duplex arteriography; DM, diabetes mellitus; N/A, not applicable.
Table II. Bypass characteristics
DA CA
N(%) N(%) P value*
Inflow (artery) .03
Common femoral 7 (30) 15 (30)
Superficial femoral 16 (70) 23 (46)
AK popliteal 0 ( 12 (24)
Outflow (artery) .21
Anterior tibial/dorsalis pedis 10 (43) 20 (40)
Posterior tibial 8 (35) 28 (56)
BK popliteal 1 (5) 2 (4)
Peroneal 2 (9) —
Anterior lateral malleolar 1 (4) —
Lateral tarsal 1 (4) —
Conduit .34
ISSV 15 (65) 35 (70)
RSV 5 (22) 6 (12)
Composite vein 2 (8) 7 (14)
Arm vein 1 (4) 2 (4)
*All P values determined with regression analysis.
AK, Above knee; BK, below knee; CA, contrast arteriography; DA, duplex arteriography; ISSV, in situ saphenous vein; RSV, right subclavian vein.
patients who underwent similar procedures based on CA
between 1996 and 1998. There were no statistically sig-
nificant differences in age, sex, smoking history, diabetes,
or renal failure between the DA and CA groups according
to Fisher exact testing. However, there were more patients
with hypertension in the CA group than in the DA group.
The indication for surgery in all patients was critical limb
ischemia. In the DA group, 78% of patients had tissue loss,
whereas in the CA group 70% had tissue loss (Table I).
The operations performed and bypass characteristics
of the DA and CA groups are listed in Tables II and III.
Femoral-tibial level bypass grafts predominated in both
groups. There was no statistically significant difference in
conduit or target artery. A larger number of grafts in the
CA group had more distal inflow origin than grafts in the
DA group. Of the 23 operations performed in the DA
group, one (4%) preoperatively determined distal anasto-
motic site was abandoned intraoperatively because of
dense calcification. This change in target artery required
lengthening the original incision so that a more distal site
on the same artery could be used. There were no other
revisions necessary in the DA or CA groups based on
intraoperative completion duplex or arteriography studies.
The 12-month primary graft patency rates for the DA
and CA groups were 78% ± 9% and 70% ± 8%, respectively
(Fig 1). The difference in patency rates was not significant
(P =.72). Primary assisted and secondary patency rates
were also similar. The 12-month limb salvage rates were
comparable between the two groups (DA 70% ± 12%, CA
81% ± 7%, P = .21; Fig 2). These trends continued to 2
years, but the number of patients followed up was insuffi-
cient for meaningful statistical comparison.
Seven grafts in the DA group failed. In two patients,
overwhelming sepsis led to amputations despite patent
bypass grafts. In three patients, intimal hyperplasia caused
graft thrombosis, and in two patients poor quality vein was
thought to cause graft failure.
With routine follow-up with the DA patients, we
attempted to determine whether more specific target
artery velocity selection criteria could be determined.
Mean preoperative PSV in target arteries of patent versus
failed grafts was 49 ± 18 cm/s versus 31 ± 9 cm/s (P =
.04, Mann-Whitney U test), whereas the mean preopera-
tive EDV of target arteries in patent versus failed grafts
was 22 ± 7 cm/s versus 14 ± 8 cm/s (P = .08, Mann-
Whitney U test). A greater number of grafts with low PSV
and EDV tended to fail (Fig 3).
DISCUSSION
DA as the sole preoperative test before infragenicular
bypass graft offers many benefits, but its perceived weak-
nesses have limited its widespread acceptance. CA is still
considered the gold standard for preoperative testing before
infragenicular bypass graft because of its known reliability in
visualizing infrapopliteal arteries. However, CA also has a
known complication rate of 2%, is time-consuming, and is
costly.16 These disadvantages have created increasing inter-
est in alternative preoperative imaging studies.
DA is an attractive alternative to CA because it is a non-
invasive, relatively inexpensive, low-risk procedure. Some
authors think that DA gives more accurate information
about the extent of lower extremity arterial disease because
CA can often underestimate eccentric lesions and may be
misleading if contrast underfilling of vessels occurs.17
Recent studies by Ligush et al, Ascher et al, and Mazzariol
et al have shown excellent results with DA alone to guide
infragenicular bypass procedures. However, DA has not
gained widespread use for managing below-knee arterial
disease. There have been reports of poor visualization of the
infrapopliteal arteries with this technique, and some authors
think that adjacent or proximal disease decreases the accu-
racy of DA when examining tibial level arteries.9,18,19
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Fig 3. Scatter plots of target artery PSV and EDV measured dur-
ing preoperative DA studies. PSV numbers shown in top graph
and EDV numbers shown in bottom graph. Patent graphs are
depicted as open circles, whereas failed grafts are depicted as solid
circles.
Table III. Procedures performed
DA CA
Target site N (%) N (%)
Below-knee popliteal artery 1 (4%) 2 (4%)
Tibial/pedal level 22 (96%) 48 (96%)
Percentage correctly predicted 22 (96%) 50 (100%)
Obtaining accurate results from DA requires a high
degree of technical expertise from the sonographer per-
forming the study.20 Technologists performing DA in our
study were experienced with this technique; all attended
training courses to familiarize themselves with the proce-
dure. In addition, if a patient has severe skin ulceration or
leg edema, DA mapping of the infragenicular anatomy
may be difficult to complete successfully, though that was
not the case in our series. Therefore, we acknowledge that,
in certain instances, a preoperative imaging modality other
than DA may be more suitable.
Our study, in which early patency rates were used, con-
firms the results of Ligush et al and Ascher et al advocating
the use of DA as the sole preoperative imaging modality for
planning distal bypass graft. We chose to exclude patients
who underwent above-knee procedures because we think
that the efficacy of DA in those patients has been previ-
ously demonstrated. We performed 22 (96%) of 23 proce-
dures exactly as predicted with preoperative DA imaging.
Our 12-month patency and limb salvage rates in the DA
group were comparable to patients who underwent similar
procedures at our institution with CA.
A new finding in our study is that PSV and EDV mea-
surements of potential target arteries may be helpful in
selecting distal targets and in predicting graft patency.
There was a significant difference in mean PSV among
patients with patent and failed grafts in our study, whereas
the difference in mean EDV between patent and failed
grafts was nearly significant. Lower velocities may reflect
poor runoff at the site of the distal anastomosis. A low
PSV, which is a marker for severe proximal disease, may
signal a decreased opportunity for retrograde flow to con-
tribute to graft runoff. In addition, a low EDV may be
indicative of a high-resistance outflow bed. We think that
low preoperative velocity measurements in nondiseased
target artery segments may be a potential predictor of
poor outcome after distal revascularization and, thus, may
be helpful in selecting patients and specific target arteries
for bypass graft. These preliminary findings merit further
evaluation of DA-derived target artery velocities.
In summary, our initial results of infragenicular revas-
cularization based on DA alone are encouraging. DA is a
relatively inexpensive, noninvasive procedure with no
associated complications. DA offers potentially useful
hemodynamic information about the lower extremity vas-
culature that is unavailable with other imaging techniques.
Using DA alone to direct infragenicular vein bypass graft
provided similar patency and limb salvage rates when com-
pared with CA-guided vein bypass grafts in our series. A
prospective trial is planned at our institution to further
evaluate the role of DA in planning infragenicular revas-
cularization procedures.
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Unknown speaker. . . . Systolic velocity and end-diastolic
velocity as a discriminating factor in that it would seem to me in
many cases that will reflect the amount of inflow as much as it will
reflect the quality of those vessels, and perhaps there are other fac-
tors that you can measure to correlate such as what is the ABI and
what are the transmetatarsal pulse volume recordings that can
help you further determine whether those low velocities are due
to inflow factors and just more critical ischemia versus factors
about the vessels themselves.
Dr Richard R. Proia. Thank you. I would address that by say-
ing that we are not trying to hang our hat solely on velocities. We
found as an observation after looking through the data that there
were some differences in the velocity measurements; specifically,
there was a statistically significant difference with the peak systolic
velocities and a nearly significant difference in the end-diastolic
velocities. I would also like to add that we are looking at all
patients at our institution who have received a preoperative
duplex including those who have also undergone contrast arteri-
ography and we are accruing the data on velocities for all those
patients to try and come up with better selection criteria. That is
somewhere around 60 to 80 patients at the moment.
Dr Richard Cambria (Boston, Mass). Congratulations on a
nice presentation. I have a couple of questions about the com-
parison of the two groups. You mention first that your historical
comparison group was 50 consecutive patients, and the presump-
tion from your slides is that these were institutional controls com-
pared with a single surgeon prospective control, at least as
depicted on your slide.
Second question, you indicated that in the duplex group all
of these patients underwent preoperative duplex vein mapping,
which could have selected patients with preferable conduits. Was
such vein mapping used in all the historical controls?
A third question, what was your run-in experience in terms
of mapping infrageniculate arteries in the vascular laboratory
prior to initiation of the studies?
Congratulations on a nice presentation.
Dr Proia. Thank you, Dr Cambria. To address your first
question, the historical control group was a group of 50
patients at our institution who were operated on by any one of
the five surgeons at Dartmouth, so there is some variability,
although all the surgeons at our institution do use similar sur-
gical techniques.
In response to your second question, all patients at our insti-
tution who undergo distal bypass surgery get preoperative
duplex-guided vein mapping.
To address your third point, we accrued a group of 18
patients who had both duplex and contrast arteriography. Very
close correlation was seen between the findings on duplex and
contrast arteriography in these patients, which then prompted us
to try performing distal bypass surgery with just duplex alone.
Dr Michael S. Conte (Boston, Mass). I also want to congrat-
ulate you on a very nicely conducted study, and I just have two
questions. One is about the technique that I may have missed, but
how well can you delineate the outflow into the foot and can you
use this, for example, when you have a patient with a foot wound
to try and predict which vessel might give you the best direct flow
into a region?
The second question I have is whether or not you have
looked at how this compared with MRA in your current series.
Dr Proia. Thank you, Dr Conte. To address your first ques-
tion, some people are hesitant to use this technique because it
requires very skilled vascular technologists who feel comfortable
performing the mapping series. Our technologists do get images
down to the foot, and following completion of any study they
communicate directly with the primary surgeon. In order to
bypass the pedal vessels, there is a lot of communication that takes
place between the vascular tech and the surgeon about what was
seen on the study. Actually, two of the patients in the duplex arte-
riography study group had fem-plantar bypasses.
To address your second question, MRA is another good
approach for planning distal bypass. I think it shares the same
advantages of duplex since it is also noninvasive. Unfortunately,
we do not have a very extensive experience with MRA at our insti-
tution, and therefore, we could not make any meaningful com-
parisons to our data using duplex arteriography.
Dr Michael Ricci (Burlington, Vt). I wonder if you still have
a role for intraoperative bypass angiography now that you are
doing this and if so what is that role?
Dr Proia. Thank you, Dr Ricci. There are some people such
as Dr Huber from the University of Florida who feel that intra-
operative arteriography is the gold standard. There are others
who feel that intraoperative arteriography in combination with
preoperative duplex offers the best preoperative planning since
the duplex acts as a guide, while the intraoperative arteriogram
offers additional helpful information. At our institution there is a
trend as I said toward just using duplex. There are certain situa-
tions and some of our surgeons who still feel more comfortable
getting an intraoperative arteriogram after the duplex to help
plan their procedure.
Dr Jens Eldrup-Jorgensen (Portland, Me). This was an inter-
esting provocative study, but there was one factor that troubled
me a little bit, which is that semiobjective criteria were used to
assess the outcomes on a relatively short-term basis. When we are
trying to define the recipient artery, we generally use more qual-
itative characteristics, such as the size of the vessels, absence of
downstream stenosis, and continuity with the pedal arch. In a
number of cases, a completion arteriogram was done, and I won-
der if you were happy with your choice of vessel bared upon the
completion arteriogram. This raises the issue that Veith did in his
study—that sometimes they would have picked a different vessel
based upon conventional arteriography.
One of the advantages of this technique is that you are able
to assess the quality of the wall of the artery in terms of calcifica-
tion and thickness, and not just the size of the vessel. Did you
sometimes move downstream a little bit because of calcification
and other concerns?
Dr Proia. Thank you. To address your first question, I would
say that we were happy with our results at the end of the cases. As
I said earlier, there was one patient where there had to be a
change from the preoperatively selected target to a different tar-
get artery. I would also say that the way to really answer your
question is to look at our patency and limb salvage data. If you
have adequate 12-month primary patency and limb salvage rates
such as we do, you can then make the assumption that the target
artery selected was a good choice.
Second, as I stated earlier, there was more information than
just the velocities used to help select the target. Information
about plaque morphology and calcification of the arterial wall was
used in choosing the target. That information was available on the
duplex mapping report generated by the technologist.
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DISCUSSION
